Skip to main content

Loading market data...

ELAN

Elanco Animal Health Incorporated

NYSE • United states

$22.70

-$0.79

(-3.36%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Elanco Animal Health Incorporated (ELAN)

Unavailable

Quotes may be delayed

$11.34B

Market Cap

8,244,448

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Elanco Animal Health Incorporated Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 2500 INNOVATION WAY, GREENFIELD, IN
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

5 Aug 2026

Elanco Animal Health Incorporated filed Form 10-Q

Elanco Animal Health Incorporated submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

5 Aug 2026

Elanco Animal Health Incorporated reported Operating or financial results

Elanco Animal Health Incorporated filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

14 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Elanco Animal Health Incorporated.

28 May 2026

Elanco Animal Health Incorporated reported Shareholder voting results

Elanco Animal Health Incorporated filed an 8-K covering shareholder voting results.

14 May 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Elanco Animal Health Incorporated.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$530.00M

Total assets (USD)$13.56B

Total liabilities (USD)$6.97B

Shareholders' equity (USD)$6.59B

Long-term debt (USD)$3.66B

Debt due within a year (USD)$44.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.37B	Unavailable	$54.00M	$0.11	10-Q · 5 Aug 2026
Q1 2026	$1.37B	Unavailable	$57.00M	$0.11	10-Q · 6 May 2026
Q4 2025	$1.14B	Unavailable	−$276.00M	Unavailable	10-K · 24 Feb 2026
Q3 2025	$1.14B	Unavailable	−$34.00M	−$0.07	10-Q · 5 Nov 2025
Q2 2025	$1.24B	Unavailable	$11.00M	$0.02	10-Q · 7 Aug 2025
Q1 2025	$1.19B	Unavailable	$67.00M	$0.13	10-Q · 7 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $31.00

36.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

12

⏸️

Hold

2

📉

Sell

0

14 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 04:48 UTC Targets range 24.00–34.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

15

Oct 2026

Bettington Timothy J

SEE REMARKS

Open-market sale

$23.00 per share

4,350 shares

Top Shareholders

Dodge & Cox

67,397,025 shares

-2.244% change

6/30/2026

Fmr Llc

56,948,819 shares

11.828% change

6/30/2026

Blackrock, Inc.

48,849,973 shares

2.577% change

6/30/2026

Vanguard Group Inc

48,059,731 shares

-1.085% change

12/31/2025

Primecap Management Co/Ca/

45,445,012 shares

-0.864% change

6/30/2026

T. Rowe Price Investment Management, Inc.

28,750,719 shares

-16.99% change

6/30/2026

Dimensional Fund Advisors Lp

25,417,271 shares

3.629% change

6/30/2026

Vanguard Portfolio Management Llc

22,672,312 shares

0.154% change

6/30/2026

Vanguard Capital Management Llc

22,607,532 shares

1.215% change

6/30/2026

State Street Corp

16,063,046 shares

4.738% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 04:48 UTC· 1 day ago

Research coverage and investment tools

Elanco Animal Health Incorporated (ELAN) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$22.70 on 20 Oct 2026. That is 38% of the way from its 52-week low of US$19.40 to its 52-week high of US$27.98. Its market capitalisation was US$11.34 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.37B	Unavailable	$54.00M	$0.11	58.3%	—	$244.00M	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$1.37B	Unavailable	$57.00M	$0.11	57.3%	—	−$38.00M	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$1.14B	Unavailable	−$276.00M	Unavailable	51.5%	—	$46.00M	10-K · 24 Feb 2026 (opens in a new tab)
Q3 2025	$1.14B	Unavailable	−$34.00M	−$0.07	53.4%	—	$127.00M	10-Q · 5 Nov 2025 (opens in a new tab)
Q2 2025	$1.24B	Unavailable	$11.00M	$0.02	57.5%	—	$180.00M	10-Q · 7 Aug 2025 (opens in a new tab)
Q1 2025	$1.19B	Unavailable	$67.00M	$0.13	57.3%	—	−$69.00M	10-Q · 7 May 2025 (opens in a new tab)

Cash and equivalents: $530.00M
Total assets: $13.56B
Total liabilities: $6.97B
Shareholders' equity: $6.59B
Long-term debt: $3.66B
Debt due within a year: $44.00M

10-Q · 5 Aug 2026

Elanco Animal Health Incorporated filed Form 10-Q (opens in a new tab)

Elanco Animal Health Incorporated submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 5 Aug 2026

Elanco Animal Health Incorporated reported Operating or financial results (opens in a new tab)

Elanco Animal Health Incorporated filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
SCHEDULE 13G · 14 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Elanco Animal Health Incorporated.
8-K · 28 May 2026

Elanco Animal Health Incorporated reported Shareholder voting results (opens in a new tab)

Elanco Animal Health Incorporated filed an 8-K covering shareholder voting results.
SCHEDULE 13G/A · 14 May 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Elanco Animal Health Incorporated.

Insider	Date	Transaction	Shares	Average price	Filing
Bettington Timothy J SEE REMARKS	15 Oct 2026	Open-market sale (S)	−4,350	$23.00	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Dodge & Cox	6/30/2026	67,397,025	-2.244%
Fmr Llc	6/30/2026	56,948,819	11.828%
Blackrock, Inc.	6/30/2026	48,849,973	2.577%
Vanguard Group Inc	12/31/2025	48,059,731	-1.085%
Primecap Management Co/Ca/	6/30/2026	45,445,012	-0.864%
T. Rowe Price Investment Management, Inc.	6/30/2026	28,750,719	-16.99%
Dimensional Fund Advisors Lp	6/30/2026	25,417,271	3.629%
Vanguard Portfolio Management Llc	6/30/2026	22,672,312	0.154%
Vanguard Capital Management Llc	6/30/2026	22,607,532	1.215%
State Street Corp	6/30/2026	16,063,046	4.738%

Previous close: 23.49 USD
Day range: 22.03 – 23.47 USD
52-week range: 19.40 – 27.98 USD
Volume: 8,244,448
Market cap: $11.34B
Average volume: 4,544,402
EPS (FY 2025, diluted): −0.47 USD
Shares outstanding: 499.62M
Beta (5Y monthly): 1.73

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:19 UTC· 55 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for ELAN yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.